Farms.com Home   News

Crop Insurance Acreage Sets New Mark in 2017

2017 was an historic year for crop insurance, with 311 million acres enrolled in the system.  For perspective, that’s an area roughly the size of California, Texas and New York combined.
 
The good news was delivered by Mike Day, chairman of National Crop Insurance Services (NCIS), during the industry’s annual meeting, which began yesterday.
 
He also told the group that insurers backed more than $106 billion worth of crops in 2017, up $6 billion since 2016.  And farmers paid $3.7 billion out of their own pockets for insurance protection – a more than $250 million increase from the year before.
 
“Today, crop insurance protects around 90 percent of the insurable land and more than 130 different kinds of crops,” said Day, who heads Rural Community Insurance Services (RCIS) for Zurich North America.  “Congress made crop insurance the cornerstone of farm policy, and it is important not just for farmers and rural communities, but for taxpayers and consumers alike.”
 
Despite its popularity, some farm policy opponents are angling to cut crop insurance funding in the upcoming Farm Bill debate.
 
Day said that would be a mistake, pointing out Congress’ efforts to make crop insurance affordable and available for farmers and economically viable enough to encourage efficient private-sector delivery.
 
“Interrupt any of those three pillars, as some farm policy critics are advocating, and you undo all the progress that has been made over the past three decades,” he noted.
 
NCIS President Tom Zacharias echoed Day’s comments and encouraged agriculture to work hand-in-hand during the Farm Bill to defend farmers’ primary risk management tool. 
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.